Crossmark

Gold–silica hybrid nanolabels decorated with recognition and signaling bioreagents for enhanced electrochemical immunodetection of chemokine ligand-12 in colorectal cancer early diagnosis and monitoring

Crossref DOI link: https://doi.org/10.1007/s00604-025-07232-8

Published Online: 2025-05-27

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cabrero-Martín, Andrea https://orcid.org/0009-0001-0785-1495
Santiago, Sara https://orcid.org/0000-0002-1206-1455
Serafín, Verónica https://orcid.org/0000-0003-0034-8456
Montero-Calle, Ana https://orcid.org/0000-0001-5141-0454
Pingarrón, José M. https://orcid.org/0000-0003-2271-1383
Barderas, Rodrigo https://orcid.org/0000-0003-3539-7469
Campuzano, Susana https://orcid.org/0000-0002-9928-6613
Funding

Funding for this research was provided by:

Ministerio de Ciencia e Innovación (PREP2022-000170, JDC2022-048757-I, PID2022-140307OB-I00, PID2022-136351OB-I00)

AES-ISCIII (PI20CIII/00019)
License Information

Text and Data Mining valid from 2025-05-27

Version of Record valid from 2025-05-27
More Information

Article History

Received: 26 March 2025

Accepted: 8 May 2025

First Online: 27 May 2025

Declarations

:

: Not applicable

: The plasma samples from healthy and CRC patients handled and analyzed were provided by biobank of Hospital Clínico San Carlos after approval of the corresponding Ethical Committee (CEI PI 13_2020-v2). Written informed consent was obtained from all study participants.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below